Patents
Literature
2 results about "Plasma cholesterol" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Normally, the cholesterol in the plasma or serum is 60% to 80% esterified. Approximately 50% to 75% of the plasma cholesterol is transported by low-density lipoproteins (LDL) and 15% to 40% by high-density lipoproteins (HDL).
A Pharmaceutical composition compresing a pharmaceutically acceptable salt of fluvastatin.
The present invention is directed to solid, sustained-release, oral dosage form pharmaceutical compositions which contain therapeutic amount of a pharmaceutically acceptable salt of fluvastatin; hydroxypropyl methyl cellulose; and a non-ionic, hydrophilic polymer selected from the group consisting of hydroxyethyl cellulose having a number average molecular weight ranging from 90,000 to 1,300,000, hydroxypropyl cellulose having a number average molecular weight of 370,000 to 1,500,000, and poly(ethylene oxide) having a number average molecular weight ranging from 100,000 to 500,000 for the reduction of plasma cholesterol levels.
Owner:NOVARTIS AG
Compositions and methods for treating cardiovascular disease
PendingUS20260183347A1Serum reactionPlasma triglyceride
The present disclosure includes compositions and methods for treating cardiovascular disease (CVD) (e.g., cholesterol related disorders, or diseases caused or characterized by increased levels of plasma triglycerides, plasma cholesterol, or serum C-reactive protein), or symptoms thereof. The disclosure also includes compositions and methods for lowering plasma triglycerides in a subject, lowering plasma cholesterol levels in a subject, and lowering serum C-reactive protein levels in a subject.
Owner:THE BROAD INST INC +1